首页> 外文期刊>British Journal of Pharmacology >Bradykinin B_1 and B_ receptors, tumour necrosis factor α and inflammatory hyperalgesia
【24h】

Bradykinin B_1 and B_ receptors, tumour necrosis factor α and inflammatory hyperalgesia

机译:缓激肽B_1和B_受体,肿瘤坏死因子α和炎性痛觉过敏

获取原文
获取原文并翻译 | 示例
       

摘要

1. The effects of BK agonists and antagonists, and other hyperalgesic/antihyperalgesic drugs were measured (3 h after injection of hyperalgesic drugs) in a model of mechanical hyperalgesia (the end- point of which was indicated by a brief apnoea, the retraction of the head an forepaws, and muscular tremor). 2 DALBK inhibited responses to carrageenin, bradykinin, DABK, and kallidin. 3. Responses to kallidin and DABK were inhibited by indomethacin or atenolol and abolished by the combination of indomethacin + atenolol.
机译:1.在机械性痛觉过敏模型(其终点以短暂的呼吸暂停指示)时,测量了BK激动剂和拮抗剂以及其他痛觉过敏/抗痛觉过敏药物的作用(注射痛觉过敏药物后3小时)。头前额和肌肉震颤)。 2 DALBK抑制了对角叉菜胶,缓激肽,DABK和激肽的反应。 3.吲哚美辛或阿替洛尔抑制了对激肽释放酶和DABK的反应,吲哚美辛+阿替洛尔的联合作用消除了对卡利丁和DABK的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号